. Author manuscript; available in PMC: 2017 Jun 1.

Published in final edited form as: J Thorac Oncol. 2016 Mar 8;11(6):890–899. doi: 10.1016/j.jtho.2016.02.018

Table 2. Patient reported symptoms of lung cancers collected using the Symptom Tracking and Reporting (STAR) System^26-30; baseline CTCAE grades and improvement while on treatment with paclitaxel and pemetrexed with bevacizumab (PPB) by at least one grade in patients with baseline symptoms.

Symptoms Of Lung Cancers	Baseline Grades of Patient Reported Symptoms (%)			Percent of Patients with Baseline Symptoms with Improvement of at Least One Grade While on Study
Symptoms Of Lung Cancers	Grade 0	Grade 1	Grade ≥2
Fatigue	34	50	16	50%
Pain	36	46	18	82%
Dyspnea	48	36	16	77%
Cough	64	23	13	100%
Anorexia	66	25	9	86%

Table 2. Patient reported symptoms of lung cancers collected using the Symptom Tracking and Reporting (STAR) System26-30; baseline CTCAE grades and improvement while on treatment with paclitaxel and pemetrexed with bevacizumab (PPB) by at least one grade in patients with baseline symptoms.